Corvia Medical, Inc.

Corvia Medical, Inc.

Medical Equipment Manufacturing

Tewksbury, MA 2,292 followers

Corvia Medical is revolutionizing the treatment of heart failure (HF) with a novel transcatheter structural heart device

About us

Corvia Medical, Inc. is revolutionizing the treatment of heart failure with a novel transcatheter structural heart device. Founded in 2009 and headquartered in Tewksbury, MA, Corvia Medical is dedicated to transforming the standard of care for heart failure treatment, enabling patients to reclaim their lives. The Corvia® Atrial Shunt is the world’s first transcatheter device approved by the European Union to treat heart failure with preserved (HFpEF) or mid-range (HFmrEF) ejection fraction. Privately held, the company is backed by Third Rock Ventures, General Catalyst Partners, AccelMed, and Lumira Ventures, Edward Lifesciences and an undisclosed strategic investor. In the United States, the Corvia Atrial Shunt System is an investigational device and not available for commercial distribution or sale.

Website
http://www.corviamedical.com
Industry
Medical Equipment Manufacturing
Company size
11-50 employees
Headquarters
Tewksbury, MA
Type
Privately Held
Founded
2009
Specialties
medical device, hfpef, hfref, heart failure, congestive heart failure, interventional cardiology, structural heart, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, and hfmref

Locations

Employees at Corvia Medical, Inc.

Updates

Similar pages

Browse jobs

Funding

Corvia Medical, Inc. 6 total rounds

Last Round

Series unknown

US$ 54.0M

See more info on crunchbase